Best Hospitals for Mole Removal in UAE

Mole removal costs vary by technique, lesion complexity, number of moles removed, and the level of the facility. In India, at JCI- and NABH-accredited hospitals and plastic surgery centres (such as those affiliated with Apollo, Fortis, Manipal, or Kokilaben), the cost for a single mole excision ranges from approximately USD 150 to USD 500 for a standard surgical excision or shave removal, rising to USD 800–1,200 for complex lesions requiring local flap reconstruction or multiple lesion removal under sedation. Laser ablation (CO2 or Er:YAG) per lesion typically costs USD 100–300. In the UAE — at JCI-accredited hospitals and DHA-licensed dermatology and plastic surgery clinics in Dubai Healthcare City, Mediclinic, Cleveland Clinic Abu Dhabi, or American Hospital Dubai — equivalent procedures cost approximately USD 350–800 per lesion for standard excision, and USD 1,200–2,800 for complex or reconstructive cases. India is consistently 50–65% more affordable than the UAE for equivalent procedures. GAF Healthcare provides itemised, transparent cost estimates specific to your diagnosis before you travel — inclusive of consultation, surgeon fees, histopathology, dressings, and post-operative review — so there are no hidden costs upon arrival.

Most mole removals are performed as day-case outpatient procedures, meaning you will not require an overnight hospital admission. However, the duration of in-country stay before you are medically safe to board an international flight depends on the technique used and the complexity of your procedure. For laser ablation (CO2/Er:YAG) or radiofrequency shave removal of a benign mole, a minimum of 5–7 days is recommended. This allows the wound to crust over, begin re-epithelialisation, and ensures no early complications (infection, unexpected bleeding) are missed at the Day-3 and Day-5 wound reviews. For surgical excision with sutures — particularly on the face, where sutures are typically removed at Day 5–7 — a stay of 7–10 days is advised to allow suture removal and wound edge confirmation before flight. For larger excisions involving local flap reconstruction or multiple lesion removal, a 10–14 day in-country stay is recommended. The slightly reduced atmospheric pressure in aircraft cabins (equivalent to 6,000–8,000 ft altitude) does not pose a significant risk to a healing cutaneous wound per se; however, the concern is haematoma formation during pressure changes, wound desiccation in low-humidity cabin air, and the patient being far from clinical support if a wound complication occurs. Your GAF Healthcare-assigned surgeon will issue a formal fit-to-fly clearance letter before you depart, and our coordinators will ensure your wound is fully reviewed and documented prior to airport transfer.

The clinical success rate of mole removal — defined as complete excision with histologically confirmed clear margins and no recurrence at 12 months — exceeds 95–98% for benign and mildly dysplastic nevi when performed by an experienced plastic surgeon or dermatological surgeon using standard elliptical excision technique. Cosmetic satisfaction rates (patient-reported acceptable or excellent scar outcome) are above 90% in high-volume plastic surgery centres in both India and the UAE. Recurrence rates for completely excised benign nevi are below 1–2%; the main driver of recurrence is incomplete excision at the base, which is more common with shave techniques and can be identified on histopathology, allowing prompt re-excision. Regarding malignant upstaging: approximately 1–3% of lesions that appear clinically benign are reclassified as moderately or severely dysplastic — or, in rare cases, as early-stage melanoma — on formal histopathological analysis. This is precisely why GAF Healthcare's protocol mandates that every excised lesion (regardless of clinical appearance) is sent for histopathological examination with immunohistochemistry. If a mole is found to contain melanoma cells on pathology, our multidisciplinary oncology team is immediately engaged: if margins are clear and the melanoma is in situ or Stage IA (Breslow thickness <0.8 mm, no ulceration), no further surgery may be required beyond surveillance. Thicker or margin-positive melanomas require wide local re-excision and, per current AJCC/NCCN staging guidelines, sentinel lymph node biopsy (SLNB) to stage the regional lymph node basin. GAF Healthcare's oncology coordination team manages this escalation pathway seamlessly, and a full histopathology report with multidisciplinary team (MDT) recommendations is shared with the patient's home country oncologist to ensure continuity of cancer care.